Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis-Reference-Cited by-同舟云学术

Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis

Published:2015-10-13 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Kaushal Deepak,Foreman Taylor W.,Gautam Uma S.,Alvarez Xavier,Adekambi Toidi,Rangel-Moreno Javier,Golden Nadia A.,Johnson Ann-Marie F.,Phillips Bonnie L.,Ahsan Muhammad H.,Russell-Lodrigue Kasi E.,Doyle Lara A.,Roy Chad J.,Didier Peter J.,Blanchard James L.,Rengarajan Jyothi,Lackner Andrew A.,Khader Shabaana A.,Mehra Smriti

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms9533.pdf

Reference70 articles.

1. Zumla, A. et al. The WHO 2014 global tuberculosis report-further to go. Lancet Glob Health 3, e10–12 (2015).

2. Kaufmann, S. H. et al. Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review. Lancet Respir. Med. 2, 301–320 (2014).

3. Orme, I. M. Prospects for new vaccines against tuberculosis. Trends Microbiol. 3, 401–404 (1995).

4. Hingley-Wilson, S. M., Sambandamurthy, V. K. & Jacobs, W. R. Jr. Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. Nat. Immunol. 4, 949–955 (2003).

5. Kaufmann, S. H. et al. Progress in tuberculosis vaccine development and host-directed therapies-a state of the art review. Lancet Respir. Med. 2, 301–320 (2014).

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent TB and HIV therapies effectively control clinical reactivation of TB during co-infection but fail to eliminate chronic immune activation;2024-08-26

2. Phagolysosomal resistance hypothesized to be a danger signal;Scandinavian Journal of Immunology;2024-08-13

3. A broader evaluation of vaccine-induced T cell immunity against tuberculosis;Frontiers in Tuberculosis;2024-07-19

4. Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfection;JCI Insight;2024-07-02

5. TB/FLU-06E Influenza Vector-Based Vaccine in the Complex Therapy of Drug-Susceptible and Drug-Resistant Experimental Tuberculosis;Pharmaceutics;2024-06-25